1. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. (22nd January 2022) Authors: Sayed, Amr; Silveira, Marina; Assis, David; Deng, Yanhong; Gaidos, Jill; Proctor, Deborah; Al-Bawardy, Badr Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S2774 Sweet Syndrome as One of the Manifesting Symptoms of Inflammatory Bowel Disease. (October 2022) Authors: Suri, Jaspreet; Sayed, Amr Other Names: Bub Andreas W. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e1818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. Issue 3 (17th January 2023) Authors: Sayed, Amr; Assis, David N.; Silveira, Marina G.; Deng, Yanhong; Ciarleglio, Maria; Gaidos, Jill K.J.; Proctor, Deborah D.; Al-Bawardy, Badr Journal: European journal of gastroenterology & hepatology Issue: Volume 35:Issue 3(2023) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗